(UroToday.com) The American Urologic Association (AUA) annual meeting’s evolving landscape of advanced prostate cancer treatment session included a talk by Dr. Joshua Lang discussing the role of chemotherapy and treatment sequencing in patients with mCRPC. Dr. Lang notes that there are a multitude of agents available, with many different sequence options: